These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 11245430
1. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis. Goldberg GS, Jin Z, Ichikawa H, Naito A, Ohki M, El-Deiry WS, Tsuda H. Cancer Res; 2001 Feb 15; 61(4):1334-7. PubMed ID: 11245430 [Abstract] [Full Text] [Related]
2. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
3. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. Koyama S, Koike N, Adachi S. J Cancer Res Clin Oncol; 2002 Feb 01; 128(2):73-9. PubMed ID: 11862476 [Abstract] [Full Text] [Related]
4. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B. Cancer Res; 2001 Apr 15; 61(8):3330-8. PubMed ID: 11309289 [Abstract] [Full Text] [Related]
5. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Pollack IF, Erff M, Ashkenazi A. Clin Cancer Res; 2001 May 15; 7(5):1362-9. PubMed ID: 11350907 [Abstract] [Full Text] [Related]
6. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD. Cancer Res; 2002 Jun 01; 62(11):3093-9. PubMed ID: 12036919 [Abstract] [Full Text] [Related]
7. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
8. Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3. Abdollahi T, Robertson NM, Abdollahi A, Litwack G. Cancer Res; 2003 Aug 01; 63(15):4521-6. PubMed ID: 12907626 [Abstract] [Full Text] [Related]
9. Interferon (IFN)-beta induces apoptotic cell death in DHL-4 diffuse large B cell lymphoma cells through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Oehadian A, Koide N, Mu MM, Hassan F, Islam S, Yoshida T, Yokochi T. Cancer Lett; 2005 Jul 08; 225(1):85-92. PubMed ID: 15922860 [Abstract] [Full Text] [Related]
10. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Hernandez A, Thomas R, Smith F, Sandberg J, Kim S, Chung DH, Evers BM. Surgery; 2001 Aug 08; 130(2):265-72. PubMed ID: 11490359 [Abstract] [Full Text] [Related]
11. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373 [Abstract] [Full Text] [Related]
12. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Chawla-Sarkar M, Leaman DW, Borden EC. Clin Cancer Res; 2001 Jun 01; 7(6):1821-31. PubMed ID: 11410525 [Abstract] [Full Text] [Related]
13. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kazhdan I, Marciniak RA. Cancer Gene Ther; 2004 Oct 01; 11(10):691-8. PubMed ID: 15354201 [Abstract] [Full Text] [Related]
14. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P. Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094 [Abstract] [Full Text] [Related]
15. Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival? Holen I, Cross SS, Neville-Webbe HL, Cross NA, Balasubramanian SP, Croucher PI, Evans CA, Lippitt JM, Coleman RE, Eaton CL. Breast Cancer Res Treat; 2005 Aug 15; 92(3):207-15. PubMed ID: 16155791 [Abstract] [Full Text] [Related]
16. HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma. Singh TR, Shankar S, Srivastava RK. Oncogene; 2005 Jul 07; 24(29):4609-23. PubMed ID: 15897906 [Abstract] [Full Text] [Related]
17. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ. Oncogene; 2001 Oct 25; 20(48):7029-40. PubMed ID: 11704827 [Abstract] [Full Text] [Related]
18. Interferon-gamma and TRAIL in human breast tumor cells. Ruiz de Almodóvar C, López-Rivas A, Ruiz-Ruiz C. Vitam Horm; 2004 Oct 25; 67():291-318. PubMed ID: 15110183 [Abstract] [Full Text] [Related]
19. TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death. Vaculová A, Hofmanová J, Andera L, Kozubík A. Cancer Lett; 2005 Nov 08; 229(1):43-8. PubMed ID: 16157217 [Abstract] [Full Text] [Related]
20. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]